• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量多模态磁共振成像作为复发性低级别胶质瘤患者的非侵入性预后工具。

Quantitative multi-modal MR imaging as a non-invasive prognostic tool for patients with recurrent low-grade glioma.

作者信息

Neill Evan, Luks Tracy, Dayal Manisha, Phillips Joanna J, Perry Arie, Jalbert Llewellyn E, Cha Soonmee, Molinaro Annette, Chang Susan M, Nelson Sarah J

机构信息

Department of Radiology, University of California San Francisco, San Francisco,, CA, 94143, USA.

Department of Pathology and Laboratory Medicine, University of California San Francisco, San Francisco, CA, 94143, USA.

出版信息

J Neurooncol. 2017 Mar;132(1):171-179. doi: 10.1007/s11060-016-2355-y. Epub 2017 Jan 25.

DOI:10.1007/s11060-016-2355-y
PMID:28124178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5373029/
Abstract

Low-grade gliomas can vary widely in disease course and therefore patient outcome. While current characterization relies on both histological and molecular analysis of tissue resected during surgery, there remains high variability within glioma subtypes in terms of response to treatment and outcome. In this study we hypothesized that parameters obtained from magnetic resonance data would be associated with progression-free survival for patients with recurrent low-grade glioma. The values considered were derived from the analysis of anatomic imaging, diffusion weighted imaging, and H magnetic resonance spectroscopic imaging data. Metrics obtained from diffusion and spectroscopic imaging presented strong prognostic capability within the entire population as well as when restricted to astrocytomas, but demonstrated more limited efficacy in the oligodendrogliomas. The results indicate that multi-parametric imaging data may be applied as a non-invasive means of assessing prognosis and may contribute to developing personalized treatment plans for patients with recurrent low-grade glioma.

摘要

低级别胶质瘤的病程差异很大,因此患者的预后也各不相同。虽然目前的特征描述依赖于手术切除组织的组织学和分子分析,但在胶质瘤亚型中,治疗反应和预后方面仍存在很大差异。在本研究中,我们假设从磁共振数据中获得的参数将与复发性低级别胶质瘤患者的无进展生存期相关。所考虑的值来自于对解剖成像、扩散加权成像和氢磁共振波谱成像数据的分析。从扩散和波谱成像中获得的指标在整个人群中以及仅限于星形细胞瘤时都具有很强的预后能力,但在少突胶质细胞瘤中的疗效较为有限。结果表明,多参数成像数据可作为一种评估预后的非侵入性手段,并可能有助于为复发性低级别胶质瘤患者制定个性化治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c28/5373029/3bbf919598a5/nihms846942f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c28/5373029/77aa4b20676c/nihms846942f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c28/5373029/6a3674820c18/nihms846942f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c28/5373029/57f1643f6637/nihms846942f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c28/5373029/3bbf919598a5/nihms846942f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c28/5373029/77aa4b20676c/nihms846942f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c28/5373029/6a3674820c18/nihms846942f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c28/5373029/57f1643f6637/nihms846942f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c28/5373029/3bbf919598a5/nihms846942f4.jpg

相似文献

1
Quantitative multi-modal MR imaging as a non-invasive prognostic tool for patients with recurrent low-grade glioma.定量多模态磁共振成像作为复发性低级别胶质瘤患者的非侵入性预后工具。
J Neurooncol. 2017 Mar;132(1):171-179. doi: 10.1007/s11060-016-2355-y. Epub 2017 Jan 25.
2
Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.O-(2-[18F]-氟乙基)-L-酪氨酸-正电子发射断层扫描成像对低级别胶质瘤患者组织病理学特征及无进展生存期的预后价值
World Neurosurg. 2016 May;89:230-9. doi: 10.1016/j.wneu.2016.01.085. Epub 2016 Mar 9.
3
Magnetic resonance analysis of malignant transformation in recurrent glioma.复发性胶质瘤恶性转化的磁共振分析
Neuro Oncol. 2016 Aug;18(8):1169-79. doi: 10.1093/neuonc/now008. Epub 2016 Feb 23.
4
Optimizing a machine learning based glioma grading system using multi-parametric MRI histogram and texture features.利用多参数MRI直方图和纹理特征优化基于机器学习的胶质瘤分级系统。
Oncotarget. 2017 Jul 18;8(29):47816-47830. doi: 10.18632/oncotarget.18001.
5
Advances in Magnetic Resonance Imaging and Positron Emission Tomography Imaging for Grading and Molecular Characterization of Glioma.磁共振成像和正电子发射断层扫描成像在胶质瘤分级及分子特征分析中的进展
Semin Radiat Oncol. 2015 Jul;25(3):164-71. doi: 10.1016/j.semradonc.2015.02.002. Epub 2015 Feb 23.
6
Comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric MRI.使用多参数磁共振成像的脑肿瘤分割无监督分类方法比较
Neuroimage Clin. 2016 Sep 30;12:753-764. doi: 10.1016/j.nicl.2016.09.021. eCollection 2016.
7
Maximal tumor diameter in the preoperative tumor magnetic resonance imaging (MRI) T2 image is associated with prognosis of Grade II Glioma.术前肿瘤磁共振成像(MRI)T2 图像中的最大肿瘤直径与 II 级胶质瘤的预后相关。
Medicine (Baltimore). 2021 Mar 12;100(10):e24850. doi: 10.1097/MD.0000000000024850.
8
Preoperative grading of supratentorial gliomas using high or standard b-value diffusion-weighted MR imaging at 3T.使用3T高或标准b值扩散加权磁共振成像对幕上胶质瘤进行术前分级
Diagn Interv Imaging. 2017 Mar;98(3):261-268. doi: 10.1016/j.diii.2016.11.005. Epub 2016 Dec 28.
9
Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.使用定量表观扩散系数和质子磁共振波谱成像对脑胶质瘤术前肿瘤分级进行诊断检查性能的测量。
Eur J Radiol. 2011 Nov;80(2):462-70. doi: 10.1016/j.ejrad.2010.07.017. Epub 2010 Aug 13.
10
Molecular-genetic and clinicopathological prognostic factors in patients with gliomas showing total 1p19q loss: gain of chromosome 19p and histological grade III negatively correlate with patient's prognosis.显示1p19q完全缺失的胶质瘤患者的分子遗传学和临床病理预后因素:19p染色体增加和组织学III级与患者预后呈负相关。
J Neurooncol. 2017 Mar;132(1):119-126. doi: 10.1007/s11060-016-2344-1. Epub 2016 Dec 26.

引用本文的文献

1
Congress of neurological surgeons systematic review and evidence-based guidelines for the role of imaging in newly diagnosed WHO grade II diffuse glioma in adults: update.神经外科医生大会关于影像学在成人新诊断的世界卫生组织II级弥漫性胶质瘤中的作用的系统评价和循证指南:更新版
J Neurooncol. 2025 May 8. doi: 10.1007/s11060-025-05043-8.
2
Congress of Neurological Surgeons systematic review and evidence‑based guidelines on the management of recurrent diffuse low-grade glioma: update.神经外科医师大会关于复发性弥漫性低级别胶质瘤管理的系统评价和循证指南:更新版
J Neurooncol. 2025 Jan;171(1):105-130. doi: 10.1007/s11060-024-04838-5. Epub 2024 Oct 14.
3
An automated approach for predicting glioma grade and survival of LGG patients using CNN and radiomics.一种使用卷积神经网络(CNN)和影像组学预测低级别胶质瘤(LGG)患者胶质瘤分级和生存情况的自动化方法。
Front Oncol. 2022 Aug 12;12:969907. doi: 10.3389/fonc.2022.969907. eCollection 2022.
4
Automated Detection of Brain Tumor through Magnetic Resonance Images Using Convolutional Neural Network.基于卷积神经网络的磁共振图像脑肿瘤自动检测
Biomed Res Int. 2021 Nov 30;2021:3365043. doi: 10.1155/2021/3365043. eCollection 2021.
5
MRS as an Aid to Diagnose Malignant Transformation in Low-Grade Gliomas with Increasing Contrast Enhancement.磁共振波谱分析有助于诊断低级别胶质瘤恶变时对比增强的变化。
AJNR Am J Neuroradiol. 2020 Sep;41(9):1592-1598. doi: 10.3174/ajnr.A6688. Epub 2020 Jul 30.
6
MR image phenotypes may add prognostic value to clinical features in IDH wild-type lower-grade gliomas.MR 影像表型可能为 IDH 野生型低级别胶质瘤的临床特征增加预后价值。
Eur Radiol. 2020 Jun;30(6):3035-3045. doi: 10.1007/s00330-020-06683-2. Epub 2020 Feb 14.
7
Relationship of In Vivo MR Parameters to Histopathological and Molecular Characteristics of Newly Diagnosed, Nonenhancing Lower-Grade Gliomas.新诊断的非强化低级胶质瘤的体内磁共振参数与组织病理学和分子特征的关系
Transl Oncol. 2018 Aug;11(4):941-949. doi: 10.1016/j.tranon.2018.05.005. Epub 2018 Jun 18.
8
Increasing FLAIR signal intensity in the postoperative cavity predicts progression in gross-total resected high-grade gliomas.术后瘤腔 FLAIR 信号强度增高预示大体全切除高级别胶质瘤的进展。
J Neurooncol. 2018 May;137(3):631-638. doi: 10.1007/s11060-018-2758-z. Epub 2018 Mar 21.

本文引用的文献

1
Detection of 2-hydroxyglutarate in brain tumors by triple-refocusing MR spectroscopy at 3T in vivo.3T 体内三重聚焦磁共振波谱法检测脑肿瘤中的 2-羟基戊二酸。
Magn Reson Med. 2017 Jul;78(1):40-48. doi: 10.1002/mrm.26347. Epub 2016 Jul 25.
2
The comparison of clinical and biological characteristics between IDH1 and IDH2 mutations in gliomas.胶质瘤中IDH1和IDH2突变的临床与生物学特征比较。
J Exp Clin Cancer Res. 2016 May 31;35:86. doi: 10.1186/s13046-016-0362-7.
3
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.2016 年世界卫生组织中枢神经系统肿瘤分类:概述。
Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1. Epub 2016 May 9.
4
Magnetic resonance analysis of malignant transformation in recurrent glioma.复发性胶质瘤恶性转化的磁共振分析
Neuro Oncol. 2016 Aug;18(8):1169-79. doi: 10.1093/neuonc/now008. Epub 2016 Feb 23.
5
Residual low ADC and high FA at the resection margin correlate with poor chemoradiation response and overall survival in high-grade glioma patients.在高级别胶质瘤患者中,切除边缘残留的低表观扩散系数(ADC)和高各向异性分数(FA)与放化疗反应不佳及总生存期相关。
Eur J Radiol. 2016 Mar;85(3):657-64. doi: 10.1016/j.ejrad.2015.12.026. Epub 2015 Dec 31.
6
Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival.先进的磁共振成像(MRI)可能辅助低级别胶质瘤的组织学诊断,并有助于预测生存期。
J Neurooncol. 2016 Jan;126(2):279-88. doi: 10.1007/s11060-015-1960-5.
7
IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.世界卫生组织二级胶质瘤中的异柠檬酸脱氢酶(IDH)突变、1p19q共缺失和α-地中海贫血/智力发育障碍综合征X连锁基因(ATRX)缺失
Oncotarget. 2015 Oct 6;6(30):30295-305. doi: 10.18632/oncotarget.4497.
8
Imaging tumor metabolism using in vivo magnetic resonance spectroscopy.利用体内磁共振波谱成像技术对肿瘤代谢进行成像。
Cancer J. 2015 Mar-Apr;21(2):123-8. doi: 10.1097/PPO.0000000000000097.
9
Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab.新诊断的胶质母细胞瘤患者接受放射治疗、替莫唑胺、厄洛替尼和贝伐单抗治疗时,ADC指标的比较及其与预后的关联。
J Neurooncol. 2015 Jan;121(2):331-9. doi: 10.1007/s11060-014-1636-6. Epub 2014 Oct 29.
10
A prognostic model based on preoperative MRI predicts overall survival in patients with diffuse gliomas.一种基于术前磁共振成像的预后模型可预测弥漫性胶质瘤患者的总生存期。
AJNR Am J Neuroradiol. 2014 Jun;35(6):1096-102. doi: 10.3174/ajnr.A3837. Epub 2014 Jan 23.